시장보고서
상품코드
1901514

불면증 보충제 시장 : 제형별, 원료별, 제품별, 유통 채널별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

Insomnia Supplements Market, By Dosage Form, By Source, By Product, By Distribution Channel, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 375 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

불면증 보충제 시장 규모는 2024년에 43억 5,698만 달러로 평가되었으며, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 13.2%를 나타낼 전망입니다.

불면증 보충제는 더 빨리 잠을 자고, 더 길게 잠을 자고, 전체적으로 수면의 질을 향상시키는 상용 약물입니다. 일반적으로 멜라토닌, 마그네슘, 허브 추출물, 아미노산, 칸나비노이드 등의 성분을 포함하여 휴식을 촉진하고 수면주기를 조절합니다. 이러한 보충제는 일시적 또는 만성 수면 문제에 대해 자연스럽고 부드러운 지원을 요청하는 사람들에게 처방전이 필요없는 옵션을 제공합니다. 스트레스 수준의 상승과 천연 유래 수면 보조제에 대한 선호도 증가가 불면증 보충제 시장의 성장을 이끌고 있습니다. 주요 동향은 효과를 높이기 위해 멜라토닌과 식물 성분을 결합한 다기능 수식의 사용을 포함합니다. 그러나 규제 감독의 불통일과 제품 품질에 대한 우려가 시장 성장을 여전히 제한하고 있습니다. 이러한 상황에도 불구하고, 전자상거래를 통한 유통 확대와 개인화된 수면 솔루션에 대한 수요 증가는 브랜드가 혁신을 도모하고 보다 광범위한 소비자층에 도달할 수 있는 큰 성장 기회를 제공합니다.

불면증 보충제 시장 역학

만성 질환 증가가 시장 성장을 견인

만성 질환 증가 추세는 불면증 보충제 시장 전망 성장을 이끌 것으로 예측됩니다. 만성 질환은 3개월 이상 지속되고 시간이 지남에 따라 악화될 수 있는 질병의 유형입니다. 심혈관 질환, 당뇨병, 만성 통증과 같은 만성 질환을 앓고 있는 사람들은 불면증 및 기타 수면 관련 문제를 병존 질환으로 자주 경험합니다. 이러한 증가 추세는 효과적인 불면증 치료 및 관리 전략에 대한 수요를 창출하고 수면장애 관련 제품 및 서비스 시장을 촉진하고 있습니다. 미국 국립의학 도서관 산하의 국립생물공학정보센터(NCBI)에 따르면 만성질환을 가진 인구는 2020년 7,152만 2,000명에서 2050년 1억 4,266만명으로 증가할 것으로 예측됩니다. 이 결과, 만성 질환 증가 경향은 불면증 보충 산업의 성장을 가속하고 있습니다.

불면증 보충제 시장 : 세분화 분석

세계의 불면증 보충제 시장은 제형, 원료, 제품, 유통 채널, 지역에 따라 세분화됩니다.

제품별로는 멜라토닌계 보충제가 불면증 보충제 시장에서 가장 인기 있는 분야입니다. 이것은 종속성이없는 수면 보조제에 대한 소비자 수요 증가가 배경에 있습니다. 멜라토닌은 일일 리듬을 조절하고 세로토닌과 같은 기분 조절 신경 전달 물질에 영향을 미칩니다. 이 이중 효과 이외에 수면을 유발하는 능력이 함께 불안 관련 수면장애와 일반적인 스트레스를 안고있는 분들에게 매력적인 선택이되고 있습니다. 온라인 약국 및 전자상거래 플랫폼에서의 멜라토닌 판매는 택배 편의성과 건강 의식 증가로 인해 크게 증가했습니다. 2023년 1월에는 P&G 헬스사가 인도에서 「Vicks ZzzQuil NATURA」를 발매했습니다. 이것은 멜라토닌 제형의 거미로, 다음날 졸음을 일으키지 않고 신속하게 잠을 잘 수 있도록 설계되었습니다. 본 제품에는 피로감과 권태감을 경감하는 비타민 B6도 배합되어 있으며, 릴렉스 효과를 높이는 천연 카모마일과 라공급업체도 추가되어 있습니다. P&G 헬스사의 조사에 의하면, 인도인의 야간의 충분한 수면 확보율은 불과 15%, 약 60%가 때때로 불면을 경험하고 있기 때문에 이 신제품은 중요한 요구에 부응하는 것입니다.

제형별로는 캡슐이 불면증 보충제 시장에서 널리 사용되어 편리성·정량 투여·높은 소비자 기호성으로부터 최대 부문으로서 대두하고 있습니다. 캡슐은 삼키기 쉽고 붕괴가 빠르기 때문에 멜라토닌, 발레리안 뿌리, L-테아닌 등의 유효 성분이 신속하게 흡수됩니다. 이 형상은 정밀한 배합이나 서방형 옵션도 가능하게 해, 신뢰성과 일관성을 요구하는 제조자·유저에게 인기입니다. 또한 캡슐은 보존 기간이 길고 첨가 당분이나 인공 향료를 포함하지 않는 경우가 많아 클린 라벨의 동향에도 맞습니다. 2024년 12월에는 Sleepinox.com이 발레리안 뿌리, 볼라지, 아슈와간다, 글리신산 마그네슘을 함유한 천연 수면 보조 식품을 출시했습니다. 본 제품은 90 캡슐 병으로 온라인 판매되고 있으며, 편안하고 활력 회복을 가져오는 수면 촉진을 목적으로하고 있습니다.

불면증 보충제 시장 - 지역별 분석

북미는 불면증 보충제(ED) 의약품 시장에서 주요 수익원 지역이며, 그 배경에는 주로 수면장애의 높은 유병률과 주민의 건강 의식의 높음을 들 수 있습니다. 미국 전국 고령자 협의회에 따르면 미국에서는 5,000만에서 7,000만 명이 만성 수면장애를 가지고 있으며, 그 중에서도 불면증이 가장 흔합니다. 이 높은 수요를 받아 기업은 수면 부족으로 고민하는 고객의 요구에 부응하기 위해 제품의 혁신과 구색의 확충을 추진하고 있습니다. 예를 들어 2023년 5월에는 GNC사가 인지기능(특히 수면·집중력·스트레스)의 개선에 초점을 맞춘 「예방영양 수면 서포트 제품」을 발표했습니다. 건강과 웰빙에 대한 관심 증가와 온라인 약국의 편의성은이 지역 시장 성장을 뒷받침하고 있습니다.

미국의 불면증 보충제 시장 - 국가별 분석

미국은 높은 스트레스 수준, 바쁜 생활 방식, 수면 건강에 대한 의식 증가로 불면증 보충제 시장에서 가장 크고 활기찬 시장 중 하나입니다. 멜라토닌, 마그네슘, 허브 블렌드 등 자연 유래의 비처방 수면 보조제로 소비자의 강한 전환이 시장 성장을 이끌고 있습니다. 미국 수면 의학 아카데미에 의한 최근 조사에 따르면, 미국 성인의 약 30%가 입면 곤란 또는 수면 유지 곤란을 보고하고, 10%가 만성 불면증으로 고통받고, 12%가 의학적으로 만성 불면증으로 진단되었습니다. 이러한 광범위한 증상의 존재가 효과적인 시판약에 대한 수요를 끌어올리고 있으며, 강력한 온라인 소매의 침투와 개인화된 웰빙 제품에 대한 관심 증가가 이를 뒷받침하고 있습니다.

목차

제1장 불면증 보충제 시장 개요

  • 분석 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 불면증 보충제의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 불면증 보충제 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 매핑
  • 규제 체계 분석

제5장 불면증 보충제 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 불면증 보충제 시장 상황

  • 불면증 보충제 시장 점유율 분석(2024)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신생 기업 분석

제7장 불면증 보충제 시장 : 제형별

  • 개요
    • 부문별 점유율 분석 : 제형별
    • 정제
    • 액상
    • 캡슐
    • 분말
    • 기타

제8장 불면증 보충제 시장 : 원료별

  • 개요
    • 부문별 점유율 분석 : 원료별
    • 천연
    • 합성

제9장 불면증 보충제 시장 : 제품별

  • 개요
    • 부문별 점유율 분석 : 제품별
    • 미네랄
    • 발레리안 뿌리
    • 비타민
    • 멜라토닌
    • 기타

제10장 불면증 보충제 시장 : 유통 채널별

  • 개요
    • 부문별 점유율 분석 : 유통 채널별
    • 병원 약국
    • 온라인 약국
    • 소매 약국
    • 전문점

제11장 불면증 보충제 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제12장 주요 공급업체 분석 : 불면증 보충제 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 프로파일
    • Nature's Bounty
    • Nestle
    • Zarbee's Naturals
    • Olly
    • Herbalife Nutrition Ltd
    • Hims &Hers Health, Inc.
    • NOW Foods
    • Bayer
    • Herb Pharm
    • Natrol, LLC
    • Others

제13장 애널리스트의 전방위적 전망

KTH

Insomnia Supplements Market size was valued at US$ 4,356.98 Million in 2024, expanding at a CAGR of 13.2% from 2025 to 2032.

Insomnia supplements are over-the-counter products that help people fall asleep faster, stay asleep longer, and sleep better overall. They usually contain ingredients like melatonin, magnesium, herbal extracts, amino acids, or cannabinoids, which promote relaxation and regulate sleep cycles. These supplements provide a non-prescription alternative for people looking for natural or gentle support for occasional or chronic sleep problems. Rising stress levels and a growing preference for natural sleep aids are driving the Insomnia Supplements market. A key trend is the use of multifunctional formulas that combine melatonin with botanicals to increase efficacy. However, inconsistent regulatory oversight and concerns about product quality continue to limit market growth. Despite this, growing e-commerce distribution and demand for personalized sleep solutions offer significant opportunities for brands to innovate and reach a larger consumer base.

Insomnia Supplements Market- Market Dynamics

Rising Prevalence of Chronic Diseases to Drive Market Growth

The rising prevalence of chronic diseases is expected to drive future growth in the insomnia supplements market. Chronic disease is a type of illness that lasts three months or longer and can deteriorate over time. Individuals with chronic diseases, such as cardiovascular disorders, diabetes, and chronic pain conditions, frequently have insomnia or other sleep-related problems as a comorbidity. This increased prevalence creates a demand for effective insomnia treatments and management strategies, which drives the market for sleep disorder-related products and services. According to the National Centre for Biotechnology Information (NCBI), a US-based National Library of Medicine, there will be 142.66 million people living with chronic diseases by 2050, up from 71.522 million in 2020. As a result, the rising prevalence of chronic diseases fuels the growth of the insomnia supplements industry.

Insomnia Supplements Market- Segmentation Analysis:

The Global Insomnia Supplements Market is segmented by Dosage Form, Source, Product, Distribution Channel and Region.

According to the product segment, Melatonin-based supplements are the most popular segment of the insomnia supplements market, driven by rising consumer demand for non-addictive sleep aids. Melatonin regulates circadian rhythms and affects mood-regulating neurotransmitters such as serotonin. This dual benefit, combined with its ability to induce sleep, makes it an appealing option for people experiencing anxiety-related sleep disturbances or general stress. Melatonin sales increased significantly at online pharmacies and e-commerce platforms, owing to the convenience of home delivery and growing health awareness. In January 2023, P&G Health launched Vicks ZzzQuil NATURA in India, a melatonin-infused gummy designed to help users fall asleep quickly without causing drowsiness the next day. The product also contains vitamin B6, which helps to reduce tiredness and fatigue, and it is infused with natural chamomile and lavender to promote relaxation. This launch addresses a significant need, as P&G Health discovered that only 15% of Indians get adequate sleep at night, with nearly 60% experiencing occasional sleeplessness.

By Dosage Form, Capsules are widely used in the insomnia supplement market, emerging as the largest segment due to their convenience, controlled dosage, and high consumer preference. Capsules are easier to swallow and disintegrate, allowing for faster absorption of active ingredients such as melatonin, valerian root, and L-theanine. This form factor also allows for precise formulation and controlled-release options, making it popular with manufacturers and users looking for dependable and consistent results. Additionally, capsules have longer shelf lives and are frequently free of added sugars or artificial flavors, which aligns with clean-label trends. In December 2024, Sleepinox.com launched a natural sleep supplement formulated with valerian root, borage, ashwagandha and magnesium glycinate. The product is available online in a bottle with 90 capsules and aims to promote restful, rejuvenating sleep.

Insomnia Supplements Market- Geographical Insights

North America is a significant revenue-generating region in the Insomnia Supplements (ED) drugs market, owing primarily to the high prevalence of sleep disorders and rising health awareness among its population. According to the National Council on Aging, 50 to 70 million people in the United States have chronic sleep disorders, with insomnia being the most common. This high demand has prompted businesses to innovate and broaden their product offerings to meet the needs of sleep-deprived customers. For instance, in May 2023, GNC introduced its Preventive Nutrition Sleep Support products, which focus on improving cognitive function, particularly sleep, focus, and stress. The growing emphasis on health and wellness, as well as the convenience of online pharmacies, helps to drive market growth in this region.

United States Insomnia Supplements Market- Country Insights

The United States is one of the largest and most dynamic markets for insomnia supplements, due to high stress levels, hectic lifestyles, and a growing awareness of sleep health. The strong consumer shift toward natural, non-prescription sleep aids such as melatonin, magnesium, and herbal blends is driving market growth. According to a recent survey conducted by the American Academy of Sleep Medicine, approximately 30% of adults in the United States report difficulty falling or staying asleep, 10% suffer from chronic insomnia, and 12% have been medically diagnosed with chronic insomnia. This widespread availability drives up demand for effective over-the-counter supplements, which is bolstered by strong online retail penetration and growing interest in personalized wellness products.

Insomnia Supplements Market- Competitive Landscape:

The competitive landscape of the insomnia supplements market is characterized by the presence of numerous players, ranging from multinational pharmaceutical corporations to small and medium-sized businesses specializing in natural and herbal products. The market is highly fragmented, with companies seeking a competitive advantage through product innovation, quality, and marketing strategies. The growing demand for natural and safe sleep aid products has resulted in a surge of new entrants and the introduction of novel formulations, escalating competition.

Recent Developments:

In October 2025, Slumber introduced its Pure Sleep fast-acting gummies, which contain 20 mg of CBN and Azuca's Time Infusion(R) technology for rapid onset in minutes. The company developed the formula to help customers fall asleep faster, stay asleep longer, and wake up feeling refreshed.

In August 2025, AG1 introduced AGZ, a melatonin-free drink mix containing Magtein, saffron, and L-theanine that promotes relaxation and restorative sleep. The product was launched to support evening routines and supplement AG1's morning formula with all-day wellness benefits.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL INSOMNIA SUPPLEMENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Nature's Bounty
  • Nestle
  • Zarbee's Naturals
  • Olly
  • Herbalife Nutrition Ltd
  • Hims & Hers Health, Inc.
  • NOW Foods
  • Bayer
  • Herb Pharm
  • Natrol, LLC
  • Others

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Tablets
  • Liquid
  • Capsules
  • Powders
  • Others

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Natural
  • Synthetic

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Minerals
  • Valerian root
  • Vitamin
  • Melatonin
  • Others

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Specialty Stores

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Insomnia Supplements Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Insomnia Supplements Market Snippet by Dosage Form
    • 2.1.2. Insomnia Supplements Market Snippet by Source
    • 2.1.3. Insomnia Supplements Market Snippet by Product
    • 2.1.4. Insomnia Supplements Market Snippet by Distribution Channel
    • 2.1.5. Insomnia Supplements Market Snippet by Country
    • 2.1.6. Insomnia Supplements Market Snippet by Region
  • 2.2. Competitive Insights

3. Insomnia Supplements Key Market Trends

  • 3.1. Insomnia Supplements Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Insomnia Supplements Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Insomnia Supplements Market Opportunities
  • 3.4. Insomnia Supplements Market Future Trends

4. Insomnia Supplements Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Insomnia Supplements Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Insomnia Supplements Market Landscape

  • 6.1. Insomnia Supplements Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Insomnia Supplements Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2024 & 2032 (%)
    • 7.1.2. Tablets
    • 7.1.3. Liquid
    • 7.1.4. Capsules
    • 7.1.5. Powders
    • 7.1.6. Others

8. Insomnia Supplements Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 8.1.2. Natural
    • 8.1.3. Synthetic

9. Insomnia Supplements Market - By Product

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 9.1.2. Minerals
    • 9.1.3. Valerian root
    • 9.1.4. Vitamin
    • 9.1.5. Melatonin
    • 9.1.6. Others

10. Insomnia Supplements Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 10.1.2. Hospital Pharmacies
    • 10.1.3. Online Pharmacies
    • 10.1.4. Retail Pharmacies
    • 10.1.5. Specialty Stores

11. Insomnia Supplements Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Insomnia Supplements Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Insomnia Supplements Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Insomnia Supplements Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Insomnia Supplements Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Insomnia Supplements Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Insomnia Supplements Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Nature's Bounty
    • 12.2.2. Nestle
    • 12.2.3. Zarbee's Naturals
    • 12.2.4. Olly
    • 12.2.5. Herbalife Nutrition Ltd
    • 12.2.6. Hims & Hers Health, Inc.
    • 12.2.7. NOW Foods
    • 12.2.8. Bayer
    • 12.2.9. Herb Pharm
    • 12.2.10. Natrol, LLC
    • 12.2.11. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제